European Archives - Page 248 of 1218 - European Medical Journal

Neighbourhood Disadvantage Tied to Worse Outcomes in Idiopathic Pulmonary Fibrosis

Living in disadvantaged neighbourhoods worsens lung function and raises mortality risk for idiopathic pulmonary fibrosis patients, especially those with milder disease, according to a new study.

Antipsychotics Linked to Worsening Behaviour in Long-Term Care Residents

Antipsychotics may worsen behavioral symptoms in long-term care residents, according to a large Canadian study. Researchers found a significant association between antipsychotic use and behavioral deterioration, urging caution in prescribing these medications.

contract

Dr Dietmar Berger appointed as Gilead’s next Chief Medical Officer

Dr Dietmar Berger is set to join Gilead Sciences as Chief Medical Officer on 2 January 2025 – succeeding Dr Merdad Parsey.

Carrageenan Linked to Insulin Resistance and Inflammation in Overweight Individuals

Carrageenan, a widely used food additive, may worsen insulin resistance and inflammation in overweight individuals, a new study reveals, sparking concerns over its impact on metabolic health.

The Role of Eosinophils in Allergic Asthma

Benralizumab has shown efficacy in reducing asthma exacerbations and controlling symptoms in severe eosinophilic asthma.

How to Reduce Liver Fat Through Targeted Dietary Interventions

Lifestyle modifications, particularly dietary changes, have shown potential in reversing MASLD and steatohepatitis.

Researchers

UK improves global clinical trial ranking, but hurdles remain

The UK is regaining its position as a global hub for industry clinical trials, according to the ABPI, but challenges remain in the space.

Redefining IBD: From Patient to Pioneer

In this episode, Jonathan Sackier sits down with Philip Smith to discuss groundbreaking advancements in gastroenterology, the impact of IBD research, and how his personal journey with Crohn’s disease has influenced his career

Intracranial Haemorrhage Risk: Direct Oral Anticoagulation Versus Antiplatelet Therapy

Systematic review finds no increased intracranial haemorrhage risk with DOACs versus antiplatelets, reinforcing atrial fibrillation guidelines.

Biologics Ease Temporomandibular Joint Inflammation in Juvenile Arthritis

Biologic treatments combined with methotrexate or leflunomide show promise in reducing temporomandibular joint inflammation and improving jaw function in children with juvenile idiopathic arthritis.